Hopen Life Sciences

10 employees

Hopen Life Science Ventures is a venture capital firm, investing in the life science and healthcare sectors.

Investor insights

Sectors invested in

Biotechnology8

Medical5

Health Care5

Life Science4

Medical Device4

Therapeutics2

Medical Ultrasound2

Type 2 Diabetes2

Metabolic Syndrome2

Alzheimer's and Parkinson's Disease2

Biopharma2

Polycystic Kidney Disease2

Software1

Information Technology1

Internet1

meticulous content aggregation1

Trapelo is supported by PhDs who perform continuous1

contextualization of all published clinical evidence related to genomic changes and targeted therapies in oncology.1

curation1

Information Services1

Funding rounds participated in

$20M sweet spot round size

Most of their 12 investments are in rounds between $5.5M and $30M

Investor type

Private Equity Firm

Venture Capital

Basic info

Industry

financial services

Sectors

Date founded

2008

Investments made

Delphinus Medical Technologies, Inc. raised $30M on September 13, 2022

Investors: Northcoast Technologies, Venture Investors and Hopen Life Sciences

Undisclosed raised $40M on April 11, 2017

Investors: Renaissance Venture Capital Fund, Frazier Healthcare Partners, Adams Street Partners, Novo Holdings and Hopen Life Sciences

Delphinus Medical Technologies, Inc. raised $40M on September 10, 2015

Investors: Northcoast Technologies, Beringea, Venture Investors and Hopen Life Sciences

NeoChord raised $20M on June 9, 2015

Investors: COrporacion Hermanos Vazquez S.A de C.V, TGap Ventures, Heron Capital and Hopen Life Sciences

Prevacept Infection Control, Inc. raised $11M on September 11, 2014

Investors: Venture Investors, Charter Life Sciences, CareFusion and Hopen Life Sciences

Sierra Oncology raised $60M on April 21, 2014

Investors: Capital Midwest Fund, Frazier Healthcare Partners, OrbiMed Advisors, RA Capital Management, L.P., Vivo Capital and Hopen Life Sciences

Bjönd raised $3.3M on April 4, 2014

Investors: Tri-Star Health Partners, Draper Triangle Ventures and Hopen Life Sciences

Tolera Therapeutics, Inc. raised $5.5M on October 16, 2012

Investors: Triathlon Medical Ventures and Hopen Life Sciences

Trapelo raised $7.2M on July 18, 2011

Investors: Chrysalis Ventures, Beringea and Hopen Life Sciences

Metabolic Solutions Development Company raised $24M on October 24, 2010

Investors: Hopen Life Sciences